Dividends Calendar Earnings Calendar
ABUS

ABUS | Arbutus Biopharma Corp

Arbutus Biopharma Corp
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Warminster, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 361.41M
  • Prev closed: 3.9
  • Open: 4.04
  • High: 4.16
  • Low: 3.81
  • 52 week low: 0.88
  • 52 week high: 9.02
  • Dividends:No Dividends

Next ER: May 5, 2022  Before Market Opens



Top Stories (ABUS)

    About the Company

    Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 4, 2022
    May 5, 2022-0.11 / -0.1812.58M / 3.38MBeat!
    March 3, 2022-0.15 / -0.193.21M / 2.88MBeat!
    November 4, 2021-0.24 / -0.2383.34M / 2.39MBeat!
    August 5, 2021-0.23 / -0.2252.33M / 2.12MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 5, 2022 2.550 2.525
    2.560
    2.420
    1.21M 2.41%
    May 4, 2022 2.490 2.380
    2.490
    2.280
    1.02M 2.89%
    May 3, 2022 2.420 2.420
    2.510
    2.385
    654.01K -0.82%
    May 2, 2022 2.440 2.370
    2.490
    2.330
    1.34M 4.72%
    Apr 29, 2022 2.330 2.400
    2.510
    2.330
    545.65K -4.12%
    Apr 28, 2022 2.430 2.460
    2.490
    2.260
    1.37M 0%
    Apr 27, 2022 2.430 2.490
    2.530
    2.420
    685.99K -2.02%
    Apr 26, 2022 2.480 2.570
    2.610
    2.480
    813.27K -5.7%
    Apr 25, 2022 2.630 2.530
    2.680
    2.530
    1.21M 2.73%
    Apr 22, 2022 2.560 2.480
    2.585
    2.450
    1.50M 1.59%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:76

    News

    News for (ABUS)

    This company doesn't provide a dividend.


    Talk about Arbutus Biopharma Corp below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 5, 2022 (Same day)

    hain shop cx syna sq gpro clls w z k lamr d 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    WikipediaTwitterLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet